Skip to Content

Cipla 125 (Topiramate 200 mg)

This pill with imprint "Cipla 125" is Pink, Capsule-shape and has been identified as Topiramate 200 mg. It is supplied by Cipla USA Inc..

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; bipolar disorder; borderline personality disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Cipla 125

Topiramate

Imprint:
Cipla 125
Strength:
200 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cipla USA Inc.
National Drug Code (NDC):
69097-0125

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide